Neuronetics, Inc. (STIM)

USD 4.58

(2.69%)

Total Liabilities Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual total liabilities in 2023 was 81.64 Million USD , up 36.47% from previous year.
  • Neuronetics, Inc.'s latest quarterly total liabilities in 2024 Q2 was 77.42 Million USD , up 1.67% from previous quarter.
  • Neuronetics, Inc. reported annual total liabilities of 59.82 Million USD in 2022, up 6.74% from previous year.
  • Neuronetics, Inc. reported annual total liabilities of 56.04 Million USD in 2021, up 5.42% from previous year.
  • Neuronetics, Inc. reported quarterly total liabilities of 77.42 Million USD for 2024 Q2, up 1.67% from previous quarter.
  • Neuronetics, Inc. reported quarterly total liabilities of 55.04 Million USD for 2023 Q3, up 0.24% from previous quarter.

Annual Total Liabilities Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Total Liabilities of Neuronetics, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 81.64 Million USD 36.47%
2022 59.82 Million USD 6.74%
2021 56.04 Million USD 5.42%
2020 53.16 Million USD 1.62%
2019 52.31 Million USD 13.78%
2018 45.98 Million USD -80.15%
2017 231.59 Million USD 14.69%
2016 201.92 Million USD 0.0%

Peer Total Liabilities Comparison of Neuronetics, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -102.956%
Biodesix, Inc. 94.51 Million USD 13.622%
bioAffinity Technologies, Inc. 3.36 Million USD -2325.246%
Castle Biosciences, Inc. 86.54 Million USD 5.663%
DarioHealth Corp. 38.24 Million USD -113.468%
Exact Sciences Corporation 3.32 Billion USD 97.545%
IDEXX Laboratories, Inc. 1.77 Billion USD 95.402%
Illumina, Inc. 4.36 Billion USD 98.13%
Intelligent Bio Solutions Inc. 5.59 Million USD -1359.003%
iSpecimen Inc. 6.07 Million USD -1243.208%
Standard BioTools Inc. 159.86 Million USD 48.931%
23andMe Holding Co. 206.64 Million USD 60.493%
Medpace Holdings, Inc. 1.09 Billion USD 92.564%
NeoGenomics, Inc. 739.69 Million USD 88.963%
Inotiv, Inc. 588.04 Million USD 86.116%
Psychemedics Corporation 6.59 Million USD -1137.36%
Prenetics Global Limited 44.01 Million USD -85.492%
Precipio, Inc. 3.67 Million USD -2123.339%
RadNet, Inc. 2.07 Billion USD 96.062%
Sotera Health Company 2.68 Billion USD 96.961%
Star Equity Holdings, Inc. 21.67 Million USD -276.66%
Exagen Inc. 34.25 Million USD -138.368%
Natera, Inc. 691.79 Million USD 88.199%
Aspira Women's Health Inc. 8.62 Million USD -846.343%
Neogen Corporation 1.44 Billion USD 94.331%
Myriad Genetics, Inc. 312.9 Million USD 73.908%
ICON Public Limited Company 7.74 Billion USD 98.946%
Bionano Genomics, Inc. 118.24 Million USD 30.957%
CareDx, Inc 223.28 Million USD 63.437%
Check-Cap Ltd. 1.33 Million USD -6038.421%
Twist Bioscience Corporation 152.97 Million USD 46.63%
Guardant Health, Inc. 1.62 Billion USD 94.984%
BioNexus Gene Lab Corp. 1.74 Million USD -4586.783%
Fulgent Genetics, Inc. 139.82 Million USD 41.611%
Sera Prognostics, Inc. 25.28 Million USD -222.909%
OPKO Health, Inc. 622.47 Million USD 86.885%
Personalis, Inc. 95.65 Million USD 14.653%
Applied DNA Sciences, Inc. 8.77 Million USD -829.94%
Star Equity Holdings, Inc. 21.67 Million USD -276.66%
MDxHealth SA 121.92 Million USD 33.039%
Prenetics Global Limited 44.01 Million USD -85.492%
ENDRA Life Sciences Inc. 1.09 Million USD -7354.73%
Mainz Biomed B.V. 12.15 Million USD -571.401%
Trinity Biotech plc 83.38 Million USD 2.09%
bioAffinity Technologies, Inc. 3.36 Million USD -2325.246%